Bottom line
BSVSX vs RMFGX: the short answer
BSVSX (Baird Equity Opportunity Fund) and RMFGX (American Mutual Fund) are both mutual funds.
But RMFGX is far broader, holding 146 positions to 36 for BSVSX, so beyond the top names it adds exposure BSVSX doesn't have.
RMFGX is cheaper at 0.27% vs 1.5% — a difference of $123 a year per $10,000 invested.
Over five years, RMFGX returned +9.8% a year vs +8.7% for BSVSX (reporting dates differ).
Updated Nov 19, 2026
BSVSX vs RMFGX side by side
| BSVSX | RMFGX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Baird | American Funds (Capital Group) |
| Category | Large Blend | Large Blend |
| Expense ratio | 1.5% | 0.27% |
| Annual cost per $10k | $150 | $27 |
| 10-yr cost on $10k (prospectus) | $2,160 | $343 |
| Max front load | — | 0% |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | +2.7% | +15.3% |
| 5-yr return (annualized) | +8.7% | +9.8% |
| 10-yr return (annualized) | +7.6% | +9.7% |
| Best quarter | +27.6% | +13.0% |
| Worst quarter | −27.1% | −18.2% |
| Net assets (fund) | $77.2M | $117.9B |
| Number of holdings | 36 | 146 |
| Portfolio turnover | 69% | 3% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
BSVSX and RMFGX share none of their top holdings.
BSVSX top 10
- First American Government Obli — 12.12%
- NCR Voyix Corp — 7.14%
- NeoGenomics Inc — 5.34%
- Sportradar Group AG — 5.27%
- RBC Bearings Inc — 5.15%
- HealthEquity Inc — 4.56%
- Norwegian Cruise Line Holdings — 4.45%
- Hayward Holdings Inc — 4.14%
- BILL Holdings Inc — 4.10%
- State Street SPDR S&P Biotech — 3.95%
RMFGX top 10
- Microsoft Corp — 5.20%
- Broadcom Inc — 4.22%
- Philip Morris International Inc — 3.24%
- Eli Lilly And Co — 3.19%
- Cisco Systems Inc — 2.83%
- Apple Inc — 2.68%
- Starbucks Corp — 2.58%
- Abbvie Inc — 2.37%
- Capital Group Central Cash Fund — 2.24%
- Jpmorgan Chase & Co — 2.22%
FAQ
What is the difference between BSVSX and RMFGX?
Which is cheaper, BSVSX or RMFGX?
Should I own both BSVSX and RMFGX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.